Navigation Links
Thomson Reuters Launches New Biomarkers Solution
Date:6/17/2008

BIOMARKERcenter is First Comprehensive and Quality Assured Biomarker

Solution Available to the Pharmaceutical Industry

PHILADELPHIA and LONDON, June 17 /PRNewswire-FirstCall/ -- Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, announced today the launch of BIOMARKERcenter, a unique comprehensive resource for biomarker intelligence. This new solution will be the first to provide the pharmaceutical industry with a framework for assessing the potential of a biomarker and to be alerted of any changes in their status.

BIOMARKERcenter covers the biomarkers identified in literature, patents, conferences, clinical trial information, and other sources for all major therapeutic areas: oncology, cardiovascular diseases, diabetes, respiratory disorders, autoimmune diseases and neurological disorders. For each therapy area, it includes not only biomarkers with established clinical usage, but also emerging uses for the biomarker. Each record has been manually created by a team of Thomson Reuters experts and provides a unique report on the biomarker using a novel lifecycle model. Other data provided will include the name, classification, biological entities/processes involved, associated drugs, role or utilities, measurement techniques, regulatory status and related diagnostic kits.

Biomarkers are measurable indicators which can be used to define a biological state. Using Biomarkers as part of a pharmaceutical R&D program can increase the success of the project by encouraging innovation, improving efficiency, saving costs and delivering a valuable advantage over competitors.

"BIOMARKERcenter is the first reliable and comprehensive database of biomarkers available to the pharmaceutical and diagnostic industries. It sets a new standard for the presentation and analysis of Biomarker information," said Jon Brett-Harris, EVP Pharmaceutical and Chemicals Markets, Thomson Reuters. "Biomarkers have the capacity to change the way pharmaceutical companies develop drugs and bring them to the market. They allow companies to improve their clinical trials design, and better understand the biology of the diseases they are targeting, and we believe BIOMARKERcenter will become an essential tool for our customers."

This new solution will be available through several delivery methods: a standalone web solution, fully integrated into Prous Science's Integrity(R) platform, or as an XML feed to internal customer databases. The Integrity integration and XML feed are available currently, with the standalone solution to be delivered later in 2008.

For further information about BIOMARKERcenter, please go to: http://scientific.thomsonreuters.com/products/biomarkercenter/

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to http://www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thomson Scientific Begins Expansion of Web of Science
2. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
6. Cardiac Science Launches Anywhere Data Management for HIS and EMR Systems
7. Cardium Launches New AWARE Clinical Study Website
8. WellCentive Launches New Secure Messaging Platform for Its Patient Registry System
9. ChanTest Launches Redesigned Web Site
10. Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
11. SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the ... the Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s ... how hardware projects are designed, built and brought to market. , The Design ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):